Medical Cannabis in Poland 2025: Growth, Stability, and Wider Access

The year 2025 brought important news for Polish patients. Data from the e-Health Center (CeZ) leaves no doubt. Medical cannabis is growing in Poland. Expert Anita Jeglińska, M.Pharm., shared the specific numbers. They are impressive.

105,000 medical cannabis patients and 5 tons of raw material. Analysis for 2025

From January 1 to December 15, 2025, pharmacies dispensed exactly 5,071 kilograms of cannabis. That’s over 5 tons of the raw material that reached patients. This figure includes both dried herb and plant extracts.

Here are the key figures for this year:

105,000 individual patients benefited from the therapy
Pharmacists filled as many as 537,000 prescriptions
The average patient purchased 5 prescriptions during this time

These numbers show that cannabis treatment is stable in Poland. Patients return for the drug regularly. The healthcare system is well-equipped to handle such a large population.

Market history: From 1 ton in 2022 to the power in 2025

To understand this success, we need to look back. In 2022 , only 1.1 tons of dried herb were sold in Poland. A year later, in 2023 , it was 4.6 tons . Today’s result (over 5 tons) shows that the market has stopped growing rapidly and has begun to mature.

The market’s value also grew. In 2022, Poles spent just under PLN 37 million on this purpose. In 2023, this amount increased to over PLN 143 million. 2025 solidified this position.

Did the 2024 prescription machine ban work?

Remember the “fever” at the end of 2024? In October 2024, patients purchased a record 90,000 packages in a single month. They spent over 42 million złoty. People stocked up because they were afraid of the new regulations.

As of November 2024, the doctor must examine you in person before issuing a prescription. This was intended to curb the use of so-called prescription machines. Data from 2025 shows something interesting: the number of patients remains high.

Despite stricter regulations, medical cannabis hasn’t disappeared. The system has become more secure, and treatment is now safer. Patients who truly need medication have learned to use in-person visits.

What does this mean for medical cannabis patients?

Access to medical cannabis is better than ever. A year ago, popular strains were only available in one in ten pharmacies. Today, the availability of the raw material is much greater. As a patient, you have more choices and greater certainty that your medication will be available.

Poland has become one of the leaders in cannabis treatment in Europe. Data for 2025 confirms this.

__

(Featured image by Budding via Unsplash)

DISCLAIMER: This article was written by a third party contributor and does not reflect the opinion of Born2Invest, its management, staff or its associates. Please review our disclaimer for more information.

This article may include forward-looking statements. These forward-looking statements generally are identified by the words “believe,” “project,” “estimate,” “become,” “plan,” “will,” and similar expressions. These forward-looking statements involve known and unknown risks as well as uncertainties, including those discussed in the following cautionary statements and elsewhere in this article and on this site. Although the Company may believe that its expectations are based on reasonable assumptions, the actual results that the Company may achieve may differ materially from any forward-looking statements, which reflect the opinions of the management of the Company only as of the date hereof. Additionally, please make sure to read these important disclosures.

First published in FaktyKonopne. A third-party contributor translated and adapted the article from the original. In case of discrepancy, the original will prevail.

Although we made reasonable efforts to provide accurate translations, some parts may be incorrect. Born2Invest assumes no responsibility for errors, omissions or ambiguities in the translations provided on this website. Any person or entity relying on translated content does so at their own risk. Born2Invest is not responsible for losses caused by such reliance on the accuracy or reliability of translated information. If you wish to report an error or inaccuracy in the translation, we encourage you to contact us.